preloader
Edit Content

About Us

BioSen Pharma was founded to address the growing need for specialized expertise in clinical research and health innovations across Africa and other emerging regions. We bring together international experience and regional understanding to make health innovations accessible where it is needed most.

Contact Info

Advancing Clinical Research and Health Innovation Across Emerging Markets

BioSen Pharma is a clinical development, medical safety, regulatory, epidemiology, health intelligence and health service provider based in Senegal, West Africa. We partner with pharmaceutical companies, biotechnology firms, academia, NGOs, governments, CROs and individuals to design and deliver impactful clinical research in Africa and other emerging markets, inform policies and build health solutions.

 

With nearly two decades of experience in clinical development, patient safety, and regulatory science across Africa, Europe, the U.S., and Latin America, our team combines international standards with deep local expertise to make research both ethical and efficient as well as improving health systems.

About Us

Who We Are

BioSen Pharma was founded to address the growing need for specialized expertise in clinical research and health innovations across Africa and other emerging regions. We bring together international experience and regional understanding to make health innovations accessible where it is needed most.

Our Mission

To advance clinical research and healthcare innovation in emerging markets through ethical, efficient, and sustainable solutions.

Our Vision

To reduce disease burden and improve quality of life by making safe and effective medical interventions accessible globally.

Expertise

Therapeutic Focus Areas

- Rare Diseases
- Infectious Diseases
- Non Communicable Diseases


Special Expertise in Biosimilars and Vaccines

We support biosimilar and vaccine developers in clinical trial design, regulatory submissions, epidemiology, medical writing, data management and safety strategy.

Global Reach

We collaborate with partners across Africa, Europe, Latin America, and the U.S.

Root Canals

Case Studies & Success Stories

Health Intelligence Hub

Knowledge That Drives Impact
The Health Intelligence Hub is BioSen Pharma’s gateway to the latest insights in health research and innovation.

What You’ll Find:

  • Market analyses and white papers.
  • Regulatory intelligence reports.
  • Health trend insights across emerging markets.-Weekly spotlights
  • Monthly newsletter: Biosimilars Beyond Borders.

Join Our Community

Subscribe to our updates and explore how data-driven intelligence can guide your next strategic move.

Training & Capacity Building

Empowering the Next Generation of Researchers
BioSen Pharma invests in people as much as in projects. We organize training and mentorship programs designed to strengthen Africa’s clinical research ecosystem.

Programs Include:

- Online and in-person training in GCP, clinical development, biosimilar and vaccine development, regulatory science, and PV.
- Mentorship programs.
- Workshops for CROs, universities, and health authorities.

 

Build Your Skills With Us — Together, we shape the future of health research excellence in Africa and emerging markets.

Collaborations & Partnerships

Partnerships That Drive Progress
BioSen Pharma collaborates with pharmaceutical companies, universities, CROs, and public health organizations.

Our Partners

We work with regional and global institutions advancing research and innovation.

Join Our Network

Interested in partnering with us? Let’s co-create impactful health solutions across Africa and beyond.

Gallery of Medizco Center

Online Medicine

Online Medicine

Online Medicine

Online Medicine

Online Medicine

Online Medicine

Service Recipient Says

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

Our Partners